AMRN · Amarin Corp Plc\Uk
$14.29
+0.34 (+2.44%)
At close · Jul 29
Market Cap
$6.14B
Shares
439.92M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Aaron D. Berg | CEO | $3,540,366 |
| Steven B. Ketchum | Executive Vice President, President of R&D and Chief Scientific Officer | $1,921,070 |
| David P. Keenan | COO | $1,616,306 |
| Jonathan Provoost | Chief Legal and Compliance Officer | $1,362,233 |
| Peter L. Fishman | CFO | $1,036,970 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Aaron D. Berg | CEO | $3,277,385 |
| Steven B. Ketchum | Executive Vice President, President of R&D and Chief Scientific Officer | $1,732,827 |
| Thomas Reilly | CFO | $1,114,760 |
| Jonathan Provoost | Chief Legal and Compliance Officer | $701,819 |
| Peter L. Fishman | CFO | $606,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Karim Mikhail | CEO | $4,880,592 |
| Aaron D. Berg | CEO | $2,448,149 |
| Steven B. Ketchum | Executive Vice President, President of R&D and Chief Scientific Officer | $2,350,567 |
| Thomas Reilly | CFO | $2,201,960 |
| Patrick Holt | CEO | $2,143,683 |
| Jonathan Provoost | Chief Legal and Compliance Officer | $659,264 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Karim Mikhail | CEO | $8,393,551 |
| Jason Marks | Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary | $2,598,112 |
| Steven B. Ketchum | Executive Vice President, President of R&D and Chief Scientific Officer | $2,014,790 |
| Michael Kalb | CFO | $1,984,651 |
| Aaron D. Berg | CEO | $1,937,306 |
| Thomas Reilly | CFO | $1,015,495 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Karim Mikhail | CEO | $5,834,553 |
| Steven B. Ketchum | Executive Vice President, President of R&D and Chief Scientific Officer | $3,374,570 |
| Aaron D. Berg | President and Chief Executive Officer (principal executive officer) | $3,292,465 |
| Michael Kalb | CFO | $3,216,971 |
| Jason Marks | Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary | $1,892,318 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| John F. Thero | CEO | $17,915,671 |
| Joseph T. Kennedy | General Counsel | $4,442,747 |
| Steven B. Ketchum | Executive Vice President, President of R&D and Chief Scientific Officer | $4,438,109 |
| Michael Kalb | CFO | $4,336,634 |
| Aaron D. Berg | President and Chief Executive Officer (principal executive officer) | $4,336,059 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| John F. Thero | CEO | $8,929,543 |
| Steven B. Ketchum | Executive Vice President, President of R&D and Chief Scientific Officer | $3,023,328 |
| Joseph T. Kennedy | General Counsel | $2,983,328 |
| Aaron D. Berg | President and Chief Executive Officer (principal executive officer) | $2,859,218 |
| Michael Kalb | CFO | $2,858,230 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| John F. Thero | CEO | $4,205,779 |
| Joseph T. Kennedy | General Counsel | $1,363,326 |
| Steven B. Ketchum | Executive Vice President, President of R&D and Chief Scientific Officer | $1,329,521 |
| Michael Kalb | CFO | $1,267,419 |
Key facts
CIK
897448
CUSIP
023111404
13F (30d)
18 filings
18 filers
Visit website
Investor relations